Show Cart
PipelineReview.com
Home
My cart / Checkout
Log in
Contact Us
Home
News Channels
Antibodies
DNA, RNA & Cells
Protein & Peptides
Small Molecules
Vaccines
More News
Free Newsletters
La Merie Biologics
New Product Release Alert
Reports
Reports
Competitor Analysis
LMP Full Report
Brief Report
Monthly Tracking Reports
FREE Reports
FREE Reports
FREE Downloads
Offers
Press Room
About Us
Home
News Channels
Antibodies
DNA, RNA & Cells
Protein & Peptides
Small Molecules
Vaccines
More News
Free Newsletters
La Merie Biologics
New Product Release Alert
Reports
Reports
Competitor Analysis
LMP Full Report
Brief Report
Monthly Tracking Reports
FREE Reports
FREE Reports
FREE Downloads
Offers
Press Room
About Us
Home
News Channels
More News
More News
01 Aug 2007
Neuren to obtain late stage compound through Hamilton Pharmaceuticals acquisition
01 Aug 2007
FDA Advisory Panel votes 22 to 1 for Avandia(R) to remain available to patients in the US
01 Aug 2007
Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
28 Jul 2007
Eisai Enters into In-licensing Agreement with Sepracor for Eszopiclone Insomnia Treatment
28 Jul 2007
ReNeuron acquires business assets of AmCyte Inc. for $4m. 27/07/07
28 Jul 2007
Medtronic to Acquire Kyphon for $3.9 Billion
28 Jul 2007
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
28 Jul 2007
GlaxoSmithKline and Targacept Form Alliance in Therapeutics for CNS-related Disorders
27 Jul 2007
Exelixis Retains Right to Develop and Commercialize XL647
27 Jul 2007
Hydra Biosciences and Pfizer Global Research & Development
26 Jul 2007
Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents
26 Jul 2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
26 Jul 2007
BioSante Pharmaceuticals Announces Positive Resultsfor its CaP Technology for Use in Aesthetic Medicine
26 Jul 2007
Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To Ortataxel, A Phase 2 Third Generation Taxane
25 Jul 2007
Kissei Entered into an Agreement with Nuon Therapeutics, Inc on Tranilast (Product Name: Rizaben(R))
25 Jul 2007
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
21 Jul 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
21 Jul 2007
Kirin and Terumo announce a basic agreement on a business collaboration
20 Jul 2007
Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
20 Jul 2007
Glenmark purchases rights to two therapeutic antibodies from Chromos
20 Jul 2007
Severin Schwan to succeed Franz B. Humer as Chief Executive of the Roche Group at the March 2008 shareholders' meeting
20 Jul 2007
Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
20 Jul 2007
NUCRYST Pharmaceuticals receives FDA clearance
20 Jul 2007
Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
19 Jul 2007
Merck Transfers Abbott Rights for Niaspan Outside the U.S.
Page 285 of 308
Start
Prev
280
281
282
283
284
285
286
287
288
289
Next
End
Currencies
Australian dollar $
British pound £
Canadian dollar $
Danish krone kr
Euro €
Japanese yen ¥
Swedish krona kr
Swiss franc CHF
United States dollar $
Shopping cart
Cart empty
Please wait
Latest report
Competitor Analysis: CDK9 and Mcl-1 Inhibitors
Featured Products
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities
Recommended Report
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins
Currencies
Australian dollar $
British pound £
Canadian dollar $
Danish krone kr
Euro €
Japanese yen ¥
Swedish krona kr
Swiss franc CHF
United States dollar $
Shopping cart
Cart empty
Please wait
Latest report
Competitor Analysis: CDK9 and Mcl-1 Inhibitors
Featured Products
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities
Recommended Report
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins
La Merie Biologics
FREE Weekly News Bulletin
2017 Sales of
Antibodies & Proteins
Get it now
New Product Alert
For La Merie Publishing
Top